Ondansetron femoral nerve block

Ondansetron as an adjuvant to ultrasound guided femoral nerve block for postoperative analgesia after arthroscopic anterior cruciate ligament reconstruction.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201608001746591

Enrollment

Registered

2016-08-20

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery postoperative analgesia

Interventions

Ultrasound guided femoral nerve block : control group(C):

Group II : ondansetron group ( O )

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age 18 ¿ 40 years either gender ASA I-II undergoing elective arthroscopic anterior cruciate ligament reconstruction (ACLR)

Exclusion criteria

Exclusion criteria: body mass index > 35 mental disorders any contraindication to regional anesthesia (e.g. local infection, coagulation abnormality, or patient refusal) known allergy to the study drug pregnancy drug or alcohol abuse a daily intake of opioid analgesics

Design outcomes

Primary

Measure	Time frame
visual analogue score of pain VAS	—

Secondary

Measure	Time frame
¿ Time of first analgesic request;¿ Total consumption of rescue analgesia ;¿ Postoperative mean arterial blood pressure, heart rate ;¿ Any concomitant events like nausea; vomiting, shivering, pruritus or respiratory complications ;¿ The overall patient satisfaction	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

Lecturer of anesthesia and ICU

Shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026